Ignoring raw material risks like unpredictable supply chains, political upheaval, or dwindling resource can seriously disrupt production, drive up costs, and weaken a company’s ability to bounce back. To stay ahead, businesses need to take a hard look at how dependent they are …
Pharmacovigilance, the science, and activities related to detecting, assessing, understanding, and preventing adverse effects or other drug-related problems, is critical in patient safety.
In today’s rapidly evolving biotechnology landscape, regulatory challenges often determine the difference between groundbreaking innovations that reach patients and those that remain trapped in development limbo. We’re excited to announce the release of our comprehensive white paper, “Navigating the Regulatory Landscape: 10 Critical Challenges for Biotech Companies,” designed to help innovators chart a successful course
In the dynamic world of pharmaceuticals, ensuring patient safety is paramount. Pharmacovigilance, the science and activities relating to detecting, assessing, understanding, and preventing adverse effects or any other drug-related problem, plays a critical role in this endeavor. Mivado GlobalPerformance Inc. is a leading provider of comprehensive pharmacovigilance solutions, helping pharmaceutical companies navigate the complexities of
Artificial intelligence (AI) rapidly transforms the biopharmaceutical industry, offering unprecedented opportunities to enhance efficiency, accuracy, and innovation. However, as AI becomes increasingly integrated into GMP-regulated processes, traditional quality management approaches must be rethought. This article delves into the critical aspects of GMP quality compliance in the AI era. It explores the top five reasons why